Structural Heart Devices Market Size, Statistics Report 2034

Structural Heart Devices Market – By Product, By Procedure, By End Use - Global Forecast, 2025 - 2034

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology and Scope

1.1&nbsp;&nbsp;&nbsp; Market scope and definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Growing burden of cardiovascular diseases

3.2.1.2&nbsp;&nbsp;&nbsp; Technological advancements

3.2.1.3&nbsp;&nbsp;&nbsp; Favorable reimbursement scenario

3.2.1.4&nbsp;&nbsp;&nbsp; Rising preference for minimally invasive procedures

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls and challenges

3.2.2.1&nbsp;&nbsp;&nbsp; Stringent regulatory policies

3.2.2.2&nbsp;&nbsp;&nbsp; Potential complications and adverse events

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Trump administration tariffs

3.5.1&nbsp;&nbsp;&nbsp; Impact on trade

3.5.1.1&nbsp;&nbsp;&nbsp; Trade volume disruptions

3.5.1.2&nbsp;&nbsp;&nbsp; Retaliatory measures

3.5.2&nbsp;&nbsp;&nbsp; Impact on the Industry

3.5.2.1&nbsp;&nbsp;&nbsp; Supply-side impact (raw materials)

3.5.2.1.1&nbsp;&nbsp;&nbsp; Price volatility in key materials

3.5.2.1.2&nbsp;&nbsp;&nbsp; Supply chain restructuring

3.5.2.1.3&nbsp;&nbsp;&nbsp; Production cost implications

3.5.2.2&nbsp;&nbsp;&nbsp; Demand-side impact (selling price)

3.5.2.2.1&nbsp;&nbsp;&nbsp; Price transmission to end markets

3.5.2.2.2&nbsp;&nbsp;&nbsp; Market share dynamics

3.5.2.2.3&nbsp;&nbsp;&nbsp; Consumer response patterns

3.5.3&nbsp;&nbsp;&nbsp; Key companies impacted

3.5.4&nbsp;&nbsp;&nbsp; Strategic industry responses

3.5.4.1&nbsp;&nbsp;&nbsp; Supply chain reconfiguration

3.5.4.2&nbsp;&nbsp;&nbsp; Pricing and product strategies

3.5.4.3&nbsp;&nbsp;&nbsp; Policy engagement

3.5.5&nbsp;&nbsp;&nbsp; Outlook and future considerations

3.6&nbsp;&nbsp;&nbsp; Reimbursement scenario

3.7&nbsp;&nbsp;&nbsp; Pricing analysis, 2024

3.8&nbsp;&nbsp;&nbsp; Technology landscape

3.9&nbsp;&nbsp;&nbsp; Future market trends

3.10&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.11&nbsp;&nbsp;&nbsp; GAP analysis

3.12&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2024

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.4&nbsp;&nbsp;&nbsp; Company market share analysis

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product, 2021 -&nbsp;2034 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Heart valve devices

5.2.1&nbsp;&nbsp;&nbsp; Surgical heart valves

5.2.2&nbsp;&nbsp;&nbsp; Transcatheter heart valves

5.3&nbsp;&nbsp;&nbsp; Annuloplasty rings

5.4&nbsp;&nbsp;&nbsp; Occluders and delivery systems

5.5&nbsp;&nbsp;&nbsp; Other products

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Procedure, 2021 -&nbsp;2034 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Replacement procedures

6.2.1&nbsp;&nbsp;&nbsp; Surgical aortic valve replacement (SAVR)

6.2.2&nbsp;&nbsp;&nbsp; Transcatheter aortic valve replacement (TAVR)

6.2.3&nbsp;&nbsp;&nbsp; Transcatheter mitral valve replacement (TMVR)

6.2.4&nbsp;&nbsp;&nbsp; Other replacement procedures

6.3&nbsp;&nbsp;&nbsp; Repair procedures

6.3.1&nbsp;&nbsp;&nbsp; Left atrial appendage closure (LAAC)

6.3.2&nbsp;&nbsp;&nbsp; Transcatheter mitral valve repair (TMVr)

6.3.3&nbsp;&nbsp;&nbsp; Transcatheter tricuspid valve repair (TTVr)

6.3.4&nbsp;&nbsp;&nbsp; Valvuloplasty

6.3.5&nbsp;&nbsp;&nbsp; Other repair procedures

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End Use, 2021 -&nbsp;2034 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Hospitals

7.3&nbsp;&nbsp;&nbsp; Ambulatory surgical centers

7.4&nbsp;&nbsp;&nbsp; Cardiac catheterization labs

7.5&nbsp;&nbsp;&nbsp; Other end use

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 -&nbsp;2034 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.3.6&nbsp;&nbsp;&nbsp; Netherlands

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; Japan

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.6&nbsp;&nbsp;&nbsp; Middle East and Africa

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp; UAE

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Abbott

9.2&nbsp;&nbsp;&nbsp; AtriCure

9.3&nbsp;&nbsp;&nbsp; BIOMERICS

9.4&nbsp;&nbsp;&nbsp; Boston Scientific

9.5&nbsp;&nbsp;&nbsp; BRAILE

9.6&nbsp;&nbsp;&nbsp; CryoLife

9.7&nbsp;&nbsp;&nbsp; Edwards

9.8&nbsp;&nbsp;&nbsp; JENAVALVE

9.9&nbsp;&nbsp;&nbsp; LEPU MEDICAL

9.10&nbsp;&nbsp;&nbsp; LivaNova

9.11&nbsp;&nbsp;&nbsp; Medtronic

9.12&nbsp;&nbsp;&nbsp; NUMED

Structural Heart Devices Market

Customize This Report

Industries

Information

Link

Global Headquarters